November 25, 2025

CG Oncology, Inc. (CGON)

⚠️ No article content returned.

..

Beam Therapeutics Inc. (BEAM) Stock Report: Analyst Ratings Reveal Potential 94% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotechnology company that has captured investor attention with its focus on precision genetic medicines targeting serious diseases. Based in Cambridge, Massachusetts, Beam is..

Evotec SE (EVO) Stock Analysis: Exploring an 80.96% Upside Potential in the Healthcare Sector

Evotec SE (EVO), a prominent player in the healthcare industry, is making waves among investors with a significant potential upside of 80.96%. With a market capitalization of $1.08 billion and..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring an 89% Potential Upside Amidst Analyst Optimism

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is captivating the attention of investors with a compelling narrative in the biotechnology sector, particularly in the field of ophthalmology. With a market capitalization of..

Harrow, Inc. (HROW) Stock Analysis: A Promising 81% Upside in the Booming Eyecare Market

Harrow, Inc. (NASDAQ: HROW), a dynamic player in the eyecare pharmaceutical sector, has been capturing the attention of investors with its impressive growth trajectory and robust product portfolio. Headquartered in..

Protagonist Therapeutics (PTGX) Stock Analysis: A Biotech Venture with a $5.48 Billion Market Cap and Promising Clinical Trials

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotechnology sector with its robust market capitalization of $5.48 billion, positioning itself as a noteworthy player in the healthcare industry. With..

Integra LifeSciences Holdings (IART) Investor Outlook: Is There a 24.2% Upside on the Horizon?

As the healthcare sector continues to evolve, investors are keeping a close eye on Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices industry. With a..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Waters with a 12% Downside

Investors eyeing the biotechnology sector often seek innovative companies with promising pipelines and strategic partnerships. Galapagos NV (GLPG), a Belgian biotech firm specializing in oncology and immunology, presents such opportunities,..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Innovator with 7.35% Potential Upside

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology company in the healthcare sector, has been making waves with its innovative products in the realm of aesthetic and reconstructive..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 82.97% Potential Upside in the Biotech Arena

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is garnering attention in the biotechnology sector with its focus on pioneering treatments for rare endocrine diseases and tumors. This clinical-stage pharmaceutical company, headquartered in..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: High Growth Potential Despite Challenges

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at an intriguing juncture for investors, offering a compelling mix of high growth potential and notable risks. With a market capitalization of $1.54 billion,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth Amid Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), operating within the healthcare sector and specializing in medical care facilities, presents a compelling case for investors seeking exposure to the U.S. healthcare market...

Structure Therapeutics Inc. (GPCR) Stock Analysis: Biotechnology Innovator with Over 105% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its innovative approach to addressing chronic diseases through novel oral small molecule therapeutics. Headquartered in South..

CONMED Corporation (CNMD): Investor Outlook on Valuation and Growth Potential with a 24.71% Upside

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is gaining significant attention from investors due to its promising growth potential and..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 34.38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specializes in the distribution of home medical equipment and services across the United States. With a current market capitalization..

Schrodinger, Inc. (SDGR) Stock Analysis: A 59% Upside Potential in the Cutting-Edge Healthcare Sector

Schrodinger, Inc. (NASDAQ: SDGR) is making waves in the healthcare sector with its innovative approach to drug development and materials science. With a market capitalization of $1.26 billion, this New..

Apogee Therapeutics (APGE) Stock Analysis: Unveiling a 42% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE) is catching the eye of investors with a compelling opportunity for growth in the biotechnology sector. As a clinical-stage company, Apogee focuses on developing novel..

Azenta, Inc. (AZTA) Stock Analysis: Is There a 2.45% Upside for Investors?

Azenta, Inc. (NASDAQ: AZTA) navigates the dynamic landscape of the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.68 billion, Azenta is a..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 51% Upside with Strategic Partnerships

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, has caught the attention of investors with its recent price activity and strategic collaborations. As of the latest trading..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking a Potential 69% Upside in the Healthcare Sector

Perrigo Company plc (PRGO), a notable player in the healthcare sector, stands at an intriguing juncture for investors. With its headquarters in Dublin, Ireland, Perrigo operates internationally through its Consumer..

Search

Funds

November 25, 2025

Search

Funds

November 25, 2025

FTSE 100

Funds